Skip to content

DECANEST

Active
Private limited companyfounded 2024active for 2 yearsKleine Dalstraat 36, 1210 Sint-Joost-ten-Node, BelgiumKBO/BCE: BE 1007.145.555
Summary

DECANEST has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €148,848 and a net result of €40,983. Its solvency ranks better than 53% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Overview

Official details

Source: KBO
Status
Active since 14-03-2024 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.357.757.521 1210 Sint-Joost-ten-Node, since 04-04-2024
Financial year end
31 December
Peppol
Reachable since 21-10-2026

Board and ownership

Board

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€63,402
▼ 52.9%
Turnover
≈ €140,000
estimated
Profit
€40,983
▼ 60.9%
Equity
€148,848
▲ 38.0%
Total assets
€225,944
▲ 60.6%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 3.49, cash €148,873Size: total assets €225,944Equity €148,848 (65.9% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 63% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 91-9
equity 65.9% of total assets
Liquidity 92=
short-term debt 23.2% · cash 65.9%
Profitability 91-9
return on assets 18.1%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 04-2025: 0.3% 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 0.3%● unchanged vs 07-2025highest value 09-2025: < 0.1%▼ -0.3 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €14,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 3.49 (4.21 in 2024), above the usual 1.5. Short-term debt is 23.2% and cash 65.9% of total assets. 34.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 53% of them on solvency, 77% on liquidity, 48% on profitability and 76% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 3.49, cash €148,873
NBB · annual accounts
lowers risk · Size: total assets €225,944
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €148,848 (65.9% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
8 days early
2024
13 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 3 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Financials

Financials · financial year 2025, micro format

Annual accounts 2025 filed on 23-07-2026 at the NBB all 2 filings

Turnover
≈ €140,000
Estimated: probably between €110,000 and €180,000
Total assets
€225,944▲ 60.6%
2024 · €140,725
Net result
€40,983▼ 60.9%
2024 · €104,864
Working capital
€130,599▲ 23.9%
2024 · €105,391
Multi-year overview
2024 to 2025, 2 financial years
Operating result
€53,184
▼ 60.4% 2025
20242025
Net result
€40,983
▼ 60.9% 2025
middle half of the sector
20242025
Equity
€148,848
▲ 38.0% 2025
middle half of the sector
20242025
Total assets
€225,944
▲ 60.6% 2025
middle half of the sector
20242025
Debt
€77,097
▲ 135% 2025
20242025
Working capital
€130,599
▲ 23.9% 2025
middle half of the sector
20242025
Solvency
65.9%
▼ 10.8pp 2025
middle half of the sector
20242025
Current ratio
3.49
▼ 0.71 2025
middle half of the sector
20242025
Return on assets (ROA)
18.1%
▼ 56.4pp 2025
middle half of the sector
20242025
Every figure per financial year
Every figure with its change against the financial year before
favourable unfavourable
Line20242025
Operating result€134,377-€53,184▼ 60.4%
Net result€104,864within the sector's middle half-€40,983within the sector's middle half▼ 60.9%
Equity€107,864within the sector's middle half-€148,848within the sector's middle half▲ 38.0%
Total assets€140,725within the sector's middle half-€225,944within the sector's middle half▲ 60.6%
Debt€32,860-€77,097▲ 135%
Working capital€105,391within the sector's middle half-€130,599within the sector's middle half▲ 23.9%
Solvency76.6%within the sector's middle half-65.9%within the sector's middle half▼ 10.8pp
Current ratio4.21within the sector's middle half-3.49within the sector's middle half▼ 0.71
Return on assets (ROA)74.5%above the sector's middle half-18.1%within the sector's middle half▼ 56.4pp
above within below The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.

The operating result for 2025 is 60% lower than in 2024.

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €225,944
Fixed assets €42,968 ▲ 17×
Current assets €182,976 ▲ 32.4%
Equity and liabilities €225,944
Equity €148,848 ▲ 38.0%
Debt €77,097 ▲ 135%
Debt's share of the balance-sheet total rises from 23.4% to 34.1%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€63,227▼
2024 · €134,627
Cash flow
€51,027▼
2024 · €105,115
Debt to equity
0.52▲
2024 · 0.30
ROE
27.5%▼
2024 · 97.2%
Interest coverage
48.79▼
2024 · over 100
Debt ≤ 1 year
€52,377▲
2024 · €32,860
Debt > 1 year
€24,720
Income taxes
€10,905▼
2024 · €29,500
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Investments

fixed assets acquired
Item20242025
Tangible fixed assets€2,724€50,538
Depreciation and write-downs of the year€250€10,044

Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 36 lines
Balance sheet Code20242025
Assets
Total assets20/58€140,725€225,944▲
Fixed assets21/28€2,474€42,968▲
Tangible fixed assets22/27€2,474€42,968▲
Furniture and vehicles24€2,474€42,968▲
Current assets29/58€138,251€182,976▲
Amounts receivable within one year40/41-€2,000
Trade receivables40-€2,000
Current investments50/53-€18,000
Cash at bank and in hand54/58€101,856€148,873▲
Deferred charges and accrued income490/1€36,395€14,103▼
Equity and liabilities
Total equity and liabilities10/49€140,725€225,944▲
Equity10/15€107,864€148,848▲
Contributions10/11€3,000€3,000=
Profit (loss) carried forward14€104,864€145,848▲
Amounts payable17/49€32,860€77,097▲
Amounts payable after more than one year17-€24,720
Financial debts170/4-€24,720
Amounts payable within one year42/48€32,860€52,377▲
Current portion of amounts payable after more than one year42-€11,272
Trade debts44€391€320▼
Suppliers440/4€391€320▼
Taxes, remuneration and social security45€31,500€40,405▲
Taxes450/3€31,500€40,405▲
Other amounts payable47/48€969€381▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€250€10,044▲
Other operating charges640/8-€175
Gross operating margin9900€134,627€63,402▼
Operating profit (loss)9901€134,377€53,184▼
Financial charges65/66B€12€1,296▲
Recurring financial charges65€12€1,296▲
Profit (loss) for the period before taxes9903€134,364€51,888▼
Income taxes67/77€29,500€10,905▼
Profit (loss) for the period9904€104,864€40,983▼
Profit (loss) for the period to be appropriated9905€104,864€40,983▼
Appropriation of the result
Profit (loss) to be appropriated9906€104,864€145,848▲
Profit (loss) brought forward from the previous period14P-€104,864

The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 23-07-2026.

Line20242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€250€10,044▲ 40×
Other operating charges640/8-€175-
Gross operating margin9900€134,627€63,402▼ 52.9%
Operating profit (loss)9901€134,377€53,184▼ 60.4%
Financial charges65/66B€12€1,296▲ 106×
Recurring financial charges65€12€1,296▲ 106×
Profit (loss) for the period before taxes9903€134,364€51,888▼ 61.4%
Income taxes67/77€29,500€10,905▼ 63.0%
Profit (loss) for the period9904€104,864€40,983▼ 60.9%
Profit (loss) for the period to be appropriated9905€104,864€40,983▼ 60.9%
Line20242025Change
Assets
Total assets20/58€140,725€225,944▲ 60.6%
Fixed assets21/28€2,474€42,968▲ 17×
Tangible fixed assets22/27€2,474€42,968▲ 17×
Furniture and vehicles24€2,474€42,968▲ 17×
Current assets29/58€138,251€182,976▲ 32.4%
Amounts receivable within one year40/41-€2,000-
Trade receivables40-€2,000-
Current investments50/53-€18,000-
Cash at bank and in hand54/58€101,856€148,873▲ 46.2%
Deferred charges and accrued income490/1€36,395€14,103▼ 61.2%
Equity and liabilities
Total equity and liabilities10/49€140,725€225,944▲ 60.6%
Equity10/15€107,864€148,848▲ 38.0%
Contributions10/11€3,000€3,000=
Profit (loss) carried forward14€104,864€145,848▲ 39.1%
Amounts payable17/49€32,860€77,097▲ 135%
Amounts payable after more than one year17-€24,720-
Financial debts170/4-€24,720-
Amounts payable within one year42/48€32,860€52,377▲ 59.4%
Current portion of amounts payable after more than one year42-€11,272-
Trade debts44€391€320▼ 18.3%
Suppliers440/4€391€320▼ 18.3%
Taxes, remuneration and social security45€31,500€40,405▲ 28.3%
Taxes450/3€31,500€40,405▲ 28.3%
Other amounts payable47/48€969€381▼ 60.7%
Line20242025Change
Profit (loss) for the period9904€104,864€40,983▼ 60.9%
+ Depreciation and write-downs630€250€10,044▲ 40×
Operating cash flow (approximation)€105,115€51,027▼ 51.5%
Investment in fixed assets (approximation)--€50,538-
Change in cash-€47,017-

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Historical observation

In July 2024, 39,278 companies had the same profile as DECANEST has now. Two years later, 95.8% were still going and 1.8% had gone bankrupt.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
95.8% was still going
2.3% stopped otherwise
1.8% went bankrupt

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of DECANEST itself is lower: < 0.1% within 12 months. It rests on far more data about DECANEST than the profile alone.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for DECANEST. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Filings with the National Bank (2)
Financial year Type Filed Reference Document
31-12-2025 micro format 23-07-2026 2026-00323143 PDF
31-12-2024 micro format 13-08-2025 2025-00374777 PDF

Board & ownership

Directors

Directors
1 director, no change since 2024
DECOT Céline Valérie Anaïs
Director (not named in the articles) · since 14-03-2024 · term without a fixed end · listed in the 2025 annual accounts, filed on 23-07-2026
Current
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Article 12. Pouvoir de représentation Chaque administrateur représente la société à l'égard des tiers et en justice, soit en demandant, soit…”
deed of 18-03-2024

Owners and capital

Shareholders

At incorporation act of 18-03-2024 ↗

Capital transactions

Capital over time
  1. 18-03-2024 Incorporation · €3,000 · 30 shares

Articles of association

Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor

Articles of association, deed of 18-03-2024 (in French)

Network & group

DECANEST shares no director with another company.

Companies at the same address

4 other companies

Connections & network

1 current director
Depth

The network starts from the directors of DECANEST. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
23-07
NBB filing Annual accounts 2025 filedNBB
micro format · 8 days before the deadline
2025
13-08
NBB filing Annual accounts 2024 filedPDF
micro format · 13 days late
2024
18-03
Gazette deed Incorporation
Starting capital €3,000 · Appointment: DECOT Céline Valérie Anaïs (director) · Registered office clause · Board rule16 points ▸
  • Registered office clause, “1210 Saint-Josse-Ten-Noode, rue du Vallon 36” (deed in French)
  • Board rule, 1
  • Director appointment, DECOT Céline Valérie Anaïs (director (not named in the articles))
  • Pre-incorporation commitments, “takeover, engagements,obligations,activités au nom et pour compte société en formation” (deed in French)
  • Founder, DECOT Céline Valérie Anaïs
  • Other provision, “régime matrimonial, séparation des biens avec société d’acquêts accessoire” (deed in French)
  • Other provision, “conjoint du comparant” (deed in French)
  • Other provision, “notaire du contrat de mariage, Notaire associé à Mons” (deed in French)
  • Other provision, “Rue des Telliers 4,7000 Mons, office notarial instrumentant” (deed in French)
  • Incorporation, “DECANEST” (deed in French)
  • Founding capital, €3,000
  • DECOT Céline Valérie Anaïs holds all the shares
  • The act holds 4 more points.

Open the act in the Belgian Official Gazette

Gazette deedNBB filing

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

DECANEST was incorporated on 14 March 2024 as a private limited company by one natural person, with a starting capital of €3,000.12 Since 2024, DECOT Céline Valérie Anaïs has served as director.3 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 18-03-2024
  3. 3National Bank, annual accounts 2025

Company details

Register details

Identity

KBO record
Name DECANEST in French
Enterprise number 1007.145.555
Legal form Private limited company
Status Active, normale toestand
Founded 14-03-2024
Entity type Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 18-03-2024 (in French)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Région de Bruxelles-Capitale, transfert en tout endroit de la Région de Bruxelles-Capitale ou de la région de langue française par simple…”
deed of 18-03-2024 (in French)

Registered office and establishments

Registered office Kleine Dalstraat 36, 1210 Sint-Joost-ten-Node, Belgium
Establishment unit DECANEST, Kleine Dalstraat 36, 1210 Sint-Joost-ten-Node since 04-04-2024 · unit number 2.357.757.521

Activities

NACEBEL 2025
86220 Specialist medical practice main activity
Codes under NACEBEL 2008
86220 Human health activities main activity

Invoicing and payment

VAT number BE 1007.145.555
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:1007145555
Registered 21-10-2026

Follow this company and you will hear the next morning if it leaves the Peppol register.

Register as of 3 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Friday of June at 18:00
deed of 18-03-2024 (in French)

Sites & property

Location
registered office establishment The establishment unit on the map
5 companies at this address See who is registered here

Buildings and parcels at the address

Ground area
93 m²
Building footprint
118 m²
Building volume
1,378 m³
Cadastral parcel Region Area Buildings Height / floors
21572B0322/00E002 Brussels 93 m² 1 · 118 m² 20.1 m · 4